Waters to merge with Becton's biosciences and diagnostics arm in $17.5 billion deal
July 14 (Reuters) - Waters Corp WAT.N will merge with Becton, Dickinson and Company's BDX.N Biosciences & Diagnostic Solutions business in a deal valued at about $17.5 billion, the companies said on Monday. (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Anil D'Silva) ((Padmanabhan.Ananthan@thomsonreuters.com;))
Recent news on Waters
See all newsU.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco
U.S. STOCKS ON THE MOVE-Expeditors International, Waters, Wayfair
Waters gains on annual profit, revenue forecasts raise
Waters Corp reports results for the quarter ended June 30 - Earnings Summary